Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 5/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5325296 | 1.00 | SRC (0.56) | SRCCYP2D6LMNAMAPK1TSHR | |
| Ammonia Solution, Strong SCHEMBL38660871 | 0.97 | SRC (0.54) | SRCCYP2D6LMNAMAPK1TSHR | |
| Hydrochloric Acid SCHEMBL6334096 | 0.97 | SRC (0.54) | SRCCYP2D6LMNAMAPK1TSHR | |
| Benzene SCHEMBL27730624 | 0.89 | CYP2D6 (0.46) | SRCCYP2D6LMNAMAPK1TSHR | |
| SCHEMBL11839188 | 0.86 | PTGS2 (0.59) | SRCCYP2D6LMNATSHRMAPT | |
| SCHEMBL9181806 | 0.84 | CYP2D6 (0.50) | SRCCYP2D6LMNAMAPK1TSHR | |
| SCHEMBL286907 | 0.82 | CYP2D6 (0.48) | SRCCYP2D6LMNAMAPK1TSHR | |
| SCHEMBL9823813 | 0.82 | CYP2D6 (0.48) | SRCCYP2D6LMNAMAPK1TSHR | |
| SCHEMBL1173291 | 0.82 | CYP2D6 (0.48) | SRCCYP2D6LMNAMAPK1TSHR | |
| SCHEMBL6960854 | 0.82 | CYP2D6 (0.48) | SRCCYP2D6LMNAMAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 640 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114752005-B | Novel method for recycling organic photocatalyst in polymerization reaction | 中国药科大学 | 2024-04-09 | — | — | CN | claimed |
| US-20230416252-A1 | PROCESS TOWARD THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE | JANSSEN PHARMACEUTICA NV (BE) | 2023-12-28 | — | — | US | claimed |
| CN-117120418-A | Process for the preparation of compound (I) | 百时美施贵宝公司 | 2023-11-24 | — | — | CN | claimed |
| EP-4225757-A1 | A PROCESS TOWARD THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}-1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B] [1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE | Bristol-Myers Squibb Company (US) | 2023-08-16 | — | — | EP | claimed |
| WO-2023137518-A1 | PLATINUM COMPLEXES | Western Sydney University (AU) | 2023-07-27 | — | — | WO | claimed |
| CN-116283894-A | Synthesis method of vinyl sulfate | 营口昌成新材料科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-111004137-B | Synthesis method of racemic phenylglycine | 浙江云涛生物技术股份有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-114752005-A | Novel method for recovering organic photocatalyst in polymerization reaction | 中国药科大学 | 2022-07-15 | — | — | CN | claimed |
| WO-2022081473-A1 | A PROCESS TOWARD THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}-1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B] [1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2022-04-21 | — | — | WO | claimed |
| CN-111704538-A | Method for preparing p-hydroxyphenylacetic acid by using microreactor | 杭州迈科瑞科技有限公司 | 2020-09-25 | — | — | CN | claimed |
| US-5137981-A | Heat resistant rubber; esterification butadiene polymer using halogenated carboxy compound | BRIDGESTONE CORPORATION (JP) | 1992-08-11 | — | — | US | claimed |
| EP-0328291-B1 | HALOGENATED POLYBUTADIENE SERIES ELASTOMERS, METHOD OF PRODUCING THE SAME, AND RUBBER COMPOSITIONS FOR TIRES CONTAINING THE ELASTOMER | Bridgestone Corporation (JP) | 1992-04-29 | — | — | EP | claimed |
| EP-0328291-A1 | Halogenated polybutadiene series elastomers, method of producing the same, and rubber compositions for tires containing the elastomer | Bridgestone Corporation (JP) | 1989-08-16 | — | — | EP | claimed |
| US-4720494-A | Anticholinergic eucatropine esters and antiperspirant use thereof | THE GILLETTE COMPANY (US) | 1988-01-19 | — | — | US | claimed |
| EP-0099802-B1 | THIENO(3,2-C) PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTICAL USE | ELF SANOFI (FR) | 1987-02-04 | — | — | EP | claimed |
| EP-0034394-B1 | PROCESS FOR THE PREPARATION OF 3'-BROMOSUBSTITUTED DEACETOXYCEPHALOSPORANIC ACID SULPHOXIDE DERIVATIVES | GIST-BROCADES N.V. (NL) | 1984-08-01 | — | — | EP | claimed |
| EP-0099802-A1 | Thieno(3,2-c) pyridine derivatives, process for their preparation and their therapeutical use | ELF SANOFI (FR) | 1984-02-01 | — | — | EP | claimed |
| US-4366315-A | Process for preparing 3'bromo-desacetoxycephalosporanic acid sulfoxide compounds | GIST-BROCADES N.V. (NL) | 1982-12-28 | — | — | US | claimed |
| EP-0034394-A2 | Process for the preparation of 3'-bromosubstituted deacetoxycephalosporanic acid sulphoxide derivatives | GIST-BROCADES N.V. (NL) | 1981-08-26 | — | — | EP | claimed |
| US-4084061-A | REARRANGEMENT OF TOLYL OR CHLOROTOLYL SODIUM, CARBOXYLATION | IHARA CHEMICAL INDUSTRY CO., LTD. (JA) | 1978-04-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230416252-A1 | PROCESS TOWARD THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE | CYP1B1, AZI2, TET1 | SRC 2134/4885CYP2D6 8/4885LMNA 4356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.